Compare TECX & JRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | TECX | JRI |
|---|---|---|
| Founded | 2019 | 2012 |
| Country | United States | United States |
| Employees | 51 | N/A |
| Industry | | Finance Companies |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 393.0M | 345.1M |
| IPO Year | N/A | N/A |
| Metric | TECX | JRI |
|---|---|---|
| Price | $33.31 | $12.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $80.40 | N/A |
| AVG Volume (30 Days) | ★ 380.4K | 235.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.38% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.70 | $10.59 |
| 52 Week High | $35.99 | $14.37 |
| Indicator | TECX | JRI |
|---|---|---|
| Relative Strength Index (RSI) | 67.84 | 37.15 |
| Support Level | $16.83 | N/A |
| Resistance Level | $35.99 | $13.34 |
| Average True Range (ATR) | 2.81 | 0.20 |
| MACD | 0.91 | -0.02 |
| Stochastic Oscillator | 80.72 | 25.57 |
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Nuveen Real Asset Income and Growth Fund is the United States-based closed-end fund. Its objective is to provide a high level of current income and long-term capital appreciation. The fund invests a majority of its managed assets in equity and debt securities issued by real asset related companies located anywhere in the world. Its plan involves investments in five security types, infrastructure common stock, REIT preferred stock and debt securities. Real asset-related companies include those engaged in owning, operating, or developing infrastructure projects, facilities, and services, as well as REITs.